
Consulting and technology group for government missions, covering cyber defence, analytics and innovation partnerships

Seoul-based venture capital firm specialising in bio and healthcare companies

Based in Seoul, Dayli Partners is a venture capital firm that concentrates on the bio and healthcare industries. The team is made up of bio healthcare specialists who look for innovative science and technology to fund and support. The firm presents its purpose as strengthening the bio ecosystem, helping companies grow alongside the industries, businesses and investors around them, while seeking to maximize the value of each investment.
The website describes four activities. The first is a TIPS and accelerator service that covers startup incubation, growth through collaboration between industry, universities and research institutes, technology commercialization with business consulting, and support for overseas expansion. The second is a venture capital fund that invests in startups and in small and medium-sized enterprises. The third is a private equity fund that provides financing for public companies, governance restructuring, inheritance and gift structuring, and mergers and acquisitions. The fourth is a genomics and data science line, which the site lists alongside the others.
The firm says its competitive advantage lies in attracting deals and investors through quick investment decisions. It has demonstrated, in its own words, the ability to make prompt decisions while still sourcing deals well, and it pursues partnered growth in which the firm and the companies it backs share in the value they create.
Dayli Partners says that until an unlisted company reaches an initial public offering and becomes stable, it actively adds value to maximize the worth of the investment. That commitment to active support, rather than passive holding, is central to how the firm describes its role. The firm wants the companies it backs to expand in step with the wider healthcare field and with its investors.
Dayli Partners is a venture capital firm in Seoul that specialises in the bio and healthcare industry. Its team is made up of bio-healthcare experts who look for scientific and technical ideas to fund and support. The firm's website also describes it as an investment group covering bio-healthcare and financial-governance sectors.
Bio and healthcare startups seeking a specialist investor, and investors wanting exposure to that field.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Dayli Partners.
Similar listings buyers compare against this one.

Consulting and technology group for government missions, covering cyber defence, analytics and innovation partnerships

Angel investor group funding seed-stage life science and healthcare companies in the Boston area

Seed and early-stage venture capital fund for life sciences companies in Greater Manchester and Cheshire

Swedish investor taking active minority stakes in Nordic software, IT services and e-commerce companies

Venture capital investor backing the next generation of consumer technology companies

Investment bank advising digital media, marketing and advertising technology companies on mergers, acquisitions and strategy

Funding programme connecting game developers with investors and publishers, run by Xsolla
Everything here links back to the same verified catalogue. Pick your next stop.